Showing results (371-380 of 391) with videos related to

Sort By:
Pageof 40
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malariaS Li, M Rodrigues, D Rodriguez, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
The Ebola virus VP35 protein functions as a type I IFN antagonistC F Basler, X Wang, E Mühlberger, et al.
Virology|January 8, 1999
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systemsA García-Sastre, A Egorov, D Matassov, et al.
Journal of Virology|November 2, 2001
Recombinant Newcastle disease virus as a vaccine vectorT Nakaya, J Cros, M S Park, et al.
Equine Veterinary Journal|March 24, 2009
Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horsesT M Chambers, M Quinlivan, T Sturgill, et al.
Cancer Research|November 24, 2001
A genetically engineered influenza A virus with ras-dependent oncolytic propertiesM Bergmann, I Romirer, M Sachet, et al.
Journal of Virology|November 1, 1995
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virusT Muster, B Ferko, A Klima, et al.
Optics Express|February 7, 2018
Efficient 240W single-mode 1018nm laser from an Ytterbium-doped 50/400µm all-solid photonic bandgap fiberFanting Kong, Guancheng Gu, Thomas W Hawkins, et al.
Pageof 40